Caribou Biosciences, Inc. Share Price
CRBUCaribou Biosciences, Inc. Stock Performance
Open $1.61 | Prev. Close $1.60 | Circuit Range N/A |
Day Range $1.57 - $1.63 | Year Range $0.66 - $3.54 | Volume 97,759 |
Average Traded $1.60 |
Caribou Biosciences, Inc. Share Price Chart
About Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Caribou Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Feb-26 | $1.61 | $1.58 | +0.00% |
10-Feb-26 | $1.61 | $1.58 | -3.07% |
09-Feb-26 | $1.57 | $1.63 | +3.82% |
06-Feb-26 | $1.53 | $1.57 | +6.44% |
05-Feb-26 | $1.59 | $1.48 | -9.51% |
04-Feb-26 | $1.57 | $1.63 | +4.15% |
03-Feb-26 | $1.55 | $1.56 | +7.19% |
FAQs on Caribou Biosciences, Inc. Share Price
Can I buy Caribou Biosciences, Inc. shares in India?
What is the share price of Caribou Biosciences, Inc.?
What is the 5 year returns of Caribou Biosciences, Inc.?
What are the high & low stock price of Caribou Biosciences, Inc. today?
What is the 52-week high and low of Caribou Biosciences, Inc. stock?